# Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma

> **NCT00503763** · PHASE2 · WITHDRAWN · sponsor: **Meir Medical Center**

## Conditions studied

- Smoldering Multiple Myeloma

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00503763
- **Lead sponsor:** Meir Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-09
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** We found out that there is another study on the same issue
- **Last updated:** 2015-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503763, "Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00503763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*